Preoperative hemoglobin-platelet ratio can significantly predict progression and mortality outcomes in patients with T1G3 bladder cancer undergoing transurethral resection of bladder tumor
Authors:
Open Access
- 3 January 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (26) , 18627-18636
Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Gang Tang1, 2, Yunpeng Zhen1, 2, Wanqin Xie3, Yinlei Wang1, 2, Feiran Chen1, 2, Chuan Qin1, 2, Han Yang1, 2, Zhiyong Du1, 2, Zhonghua Shen1, 2, Bo Zhang1, 2, Zhouliang Wu1, 2, Dawei Tian1, 2 and Hailong Hu1, 2 1Department of Urology, The Second Hospital of Tianjin Medical University, Hexi District, Tianjin 300211, China 2Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China 3Key Laboratory of Genetics and Birth Health of Hunan Province, The Family Planning Research Institute of Hunan Province, Changsha, Hunan 410126, China Correspondence to: Dawei Tian, email: jianshi001@126.com Hailong Hu, email: hhllove2004@163.com Keywords: HPR; T1G3 bladder cancer; PFS; OS; CSS Received: June 28, 2016 Accepted: November 12, 2017 Published: January 03, 2018 ABSTRACT Objective: To investigate the prognostic role of hematological biomarkers, especially hemoglobin-platelet ratio (HPR) in the oncological outcomes in stage 1 and grade 3 (T1G3) bladder cancer. Materials and Methods: We identified 457 T1G3 bladder cancer patients who underwent transurethral resection of the bladder (TURB) between 2009 and 2014. Based on hematological parameters (hemoglobin-platelet ratio (HPR), hemoglobin, and platelet counts), recurrence-free survival (RFS), progression-free survival (PFS), and overall survival (OS) and cancer-specific survival (CSS) were analyzed by using Kaplan-Meier analysis. Multivariate Cox regression model was adopted to identify the predictors of oncological outcomes. Results: Kaplan-Meier survival analysis showed that low HPR (< 0.615), low hemoglobin (< 125g/l) and elevated platelet counts (> 240 x 103/μl) were correlated with poor OS. Low HPR, but not low hemoglobin and high platelet counts, is associated with worse PFS. Low HPR and low hemoglobin, but not elevated platelet counts, are associated with worse CSS. However, no significant difference was observed in RFS according to any of these hematological markers. On multivariate analysis, low HPR (HR = 1.27, 95% CI = 0.81–1.75, P = 0.030), low hemoglobin (HR = 1.20, 95% CI = 0.79-1.84, P = 0.028) and elevated platelet counts (HR = 1.07, 95% CI = 0.72–1.32, P = 0.038) were significantly associated with OS. Low hemoglobin (HR = 1.08, 95% CI = 0.68–1.82, P = 0.041) was significantly linked with CSS. Particularly, low HPR was identified as an independent predictor of PFS (HR = 1.16, 95%CI = 0.97–1.49, P = 0.033) and CSS (HR = 1.14, 95% CI = 0.87-1.78, P = 0.029). Conclusions: Preoperative HPR can be taken into account as a factor predictive of oncological outcomes for T1G3 bladder cancer, particularly disease progression and mortality outcomes.Keywords
This publication has 33 references indexed in Scilit:
- The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancerCurrent Opinion in Urology, 2011
- Platelet adhesion and fusion to endothelial cell facilitate the metastasis of tumor cell in hypoxia-reoxygenation conditionClinical & Experimental Metastasis, 2010
- Pro-Inflammatory Cytokine-Mediated Anemia: Regarding Molecular Mechanisms of ErythropoiesisMediators of Inflammation, 2009
- Direct regulation of TWIST by HIF-1α promotes metastasisNature Cell Biology, 2008
- Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation StudyClinical Cancer Research, 2007
- Expression and Significance of Vascular Endothelial Growth Factor Receptor 2 in Bladder CancerJournal of Urology, 2006
- The hypoxic tumor microenvironment and gene expressionSeminars in Radiation Oncology, 2004
- Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug ResistanceMolecular and Cellular Biology, 2004
- Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiationExperimental Hematology, 2000
- The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year OutcomeJournal of Urology, 1997